{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:39:11Z","timestamp":1767904751811,"version":"3.49.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0198877","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T13:31:33Z","timestamp":1530883893000},"page":"e0198877","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Is it time to consider the expression of specific-pituitary hormone genes when typifying pituitary tumours?"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1052-1315","authenticated-orcid":true,"given":"Araceli","family":"Garc\u00eda-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johana","family":"Sottile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Riesgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio","family":"Simal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4622-9508","authenticated-orcid":true,"given":"Cristina","family":"Lamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hern\u00e1n","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7549-7563","authenticated-orcid":true,"given":"Antonio","family":"Pic\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","article-title":"The 2017 World Health Organization classification of tumors of the pituitary gland: a summary","volume":"134","author":"MBS Lopes","year":"2017","journal-title":"Acta Neuropathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1530\/ERC-17-0004","article-title":"From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal","volume":"24","author":"SL Asa","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","article-title":"The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas","volume":"26","author":"H Nishioka","year":"2015","journal-title":"Endocr Pathol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1507\/endocrj.K10E-389","article-title":"Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between non-pituitary and pituitary ACTH-secreting tumors","volume":"58","author":"Y Tani","year":"2011","journal-title":"Endocr J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/EJE-10-0076","article-title":"Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing\u2019s disease","volume":"163","author":"G Raverot","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1530\/EJE-07-0428","article-title":"Differential gene expression in ACTH -secreting and non-functioning pituitary tumors","volume":"157","author":"T Tateno","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11102-014-0624-3","article-title":"Silent corticotroph adenomas","volume":"18","author":"O Cooper","year":"2015","journal-title":"Pituitary"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/MED.0000000000000293","article-title":"Histological features of pituitary adenomas and sellar region masses","volume":"23","author":"BK Kleinschmidt-DeMasters","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00441-005-0033-z","article-title":"Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line","volume":"322","author":"S Miyai","year":"2005","journal-title":"Cell Tissue Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","article-title":"Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement","volume":"20","author":"FF Casanueva","year":"2017","journal-title":"Pituitary"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"DN Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e0180039","DOI":"10.1371\/journal.pone.0180039","article-title":"Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas","volume":"12","author":"L Sanchez-Tejada","year":"2017","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.endonu.2016.03.001","article-title":"El Registro Molecular de Adenomas Hipofisarios (REMAH): una apuesta de futuro de la Endocrinolog\u00eda espa\u00f1ola por la medicina individualizada y la investigaci\u00f3n traslacional","volume":"63","author":"RM Luque","year":"2016","journal-title":"Endocrinol y Nutr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1210\/jc.2013-1992","article-title":"A Cellular and Molecular Basis for the Selective Desmopressin-Induced ACTH Release in Cushing Disease Patients: Key Role of AVPR1b Receptor and Potential Therapeutic Implications","volume":"98","author":"RM Luque","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1210\/en.2007-0378","article-title":"Regulation of Growth Hormone and Prolactin Gene Expression and Secretion by Chimeric Somatostatin-Dopamine Molecules","volume":"148","author":"A Gruszka","year":"2007","journal-title":"Endocrinology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1530\/EJE-07-0806","article-title":"Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas","volume":"158","author":"A Fusco","journal-title":"Eur J Endocrinol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0303-7207(91)90110-E","article-title":"Either isoform of the dopamine D2 receptor can mediate dopaminergic repression of the rat prolactin promoter","volume":"79","author":"R McChesney","year":"1991","journal-title":"Mol Cell Endocrinol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0303-7207(89)90235-9","article-title":"Dopamine D2-receptor messenger RNA is differentially regulated by dopaminergic agents in rat anterior and neurointermediate pituitary","volume":"67","author":"DJ Autelitano","year":"1989","journal-title":"Mol Cell Endocrinol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/edrv.22.6.0451","article-title":"Dopamine as a Prolactin (PRL) Inhibitor","volume":"22","author":"N Ben-Jonathan","year":"2001","journal-title":"Endocr Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mce.2012.05.020","article-title":"Somatostatin analogs and chimeric somatostatin-dopamine molecules differentially regulate human growth hormone and prolactin gene expression and secretion in vitro","volume":"362","author":"A Gruszka","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1055\/s-0030-1252064","article-title":"Suppression of Prolactin Expression by Cabergoline Requires Prolactin Regulatory Element-binding Protein (PREB) in GH3 Cells","volume":"42","author":"W Zhang","year":"2010","journal-title":"Horm Metab Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2265.2007.03065.x","article-title":"The clinical response to somatostatin analogues in acromegaly correlates to the somatostatin receptor subtype 2a protein expression of the adenoma","volume":"68","author":"SL Fougner","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1530\/JOE-16-0332","article-title":"Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro","volume":"231","author":"A Ib\u00e1\u00f1ez-Costa","year":"2016","journal-title":"J Endocrinol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/342923a0","article-title":"Alternative splicing directs the expression of two D2 dopamine receptor isoforms","volume":"342","author":"B Giros","year":"1989","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.beem.2012.01.002","article-title":"Subclinical hyperfunctioning pituitary adenomas: The silent tumors","volume":"26","author":"O Cooper","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/acta.0.1180533","article-title":"The immunocytochemical heterogeneity of silent pituitary adenomas","volume":"118","author":"HM Heshmati","year":"1988","journal-title":"Acta Endocrinol (Copenh)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11102-018-0869-3","article-title":"Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas","volume":"21","author":"G Ntali","year":"2018","journal-title":"Pituitary"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11102-018-0864-8","article-title":"Silent corticotroph adenomas","volume":"21","author":"A Ben-Shlomo","year":"2018","journal-title":"Pituitary"},{"key":"ref29","first-page":"1170","article-title":"Clinical Outcome of Silent Subtype III Pituitary Adenomas Diagnosed by Immunohistochemistry","volume":"74","author":"TE Richardson","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/modpathol.2015.151","article-title":"Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas","volume":"29","author":"O Mete","year":"2016","journal-title":"Mod Pathol"},{"issue":"Suppl 4","key":"ref31","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","article-title":"CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008\u20132012","volume":"17","author":"QT Ostrom","year":"2015","journal-title":"Neuro Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-013-1354-5","article-title":"Epidemiology and etiopathogenesis of pituitary adenomas","volume":"117","author":"ED Aflorei","year":"2014","journal-title":"J Neurooncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0198877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T08:39:30Z","timestamp":1571560770000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0198877"}},"subtitle":[],"editor":[{"given":"Raul M.","family":"Luque","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0198877","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,6]]}}}